CPSCCPSC · Productos de consumo·N.º oficial 21089
Imatinib Mesylate Tablets 100 mg, Imatinib Mesylate Tablets 400 mg, Pregabalin Capsules 50 mg, Pregabalin Capsules 75 mg, Pregabalin Capsules 100 mg, Pregabalin Capsules 150 mg, Sevelamer Carbonate Tablets 800 mg, Tadalafil Tablets 5 mg and Tadalafil Tablets 20 mg
Publicado el 25 de febrero de 2021 · Inicio del retiro: 25 de febrero de 2021
Qué peligro representa
The products are prescription medications that were labeled and distributed by Dr. Reddy's for institutional use only. The prescription medications were distributed by third party wholesalers to retail pharmacies and could have been dispensed to consumers. The packaging of the products is not child resistant and can pose a risk of poisoning if the contents are swallowed by young children.
Qué hacer
Consumers should immediately store the recalled medications in a safe location out of reach of children and contact Dr. Reddy's for a full refund.
Detalles del retiro
- Marca
- Dr. Reddy's Laboratories, Ltd., of India
- Fabricante
- Dr. Reddy's Laboratories, Ltd., of India
- Distribuidor
- Beginning in 2018, Dr. Reddy's sold the recalled medications to wholesalers. Ultimately, these medications could have been sold to consumers at retail pharmacies in the United States at prices varying based on quantities prescribed, health insurance terms, and other factors.
- País
- US
¿Vendes productos como este?
Recalert vigila todo tu catálogo contra retiros como este, automáticamente.